Renal Cell Carcinoma
PMPH-USA Limited (Verlag)
978-1-60795-003-5 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
Edited and written by medical oncologists and surgeons, this new reference covers all aspects of renal cell cancer from pathology and molecular genetics onto diagnosis, screening and imaging. Includes all the latest on management and treatment from medical and immunotherapy through to surgical procedures. Covers future therapeutics and supportive care. The bulk of the chapters deal with practical management of the continuum of kidney cancer ranging from the small renal mass to the metastatic patient. Different treatment approaches are discussed within the context of each of these clinical scenarios and surgical and therapeutic advances are highlighted. In addition, special populations such as patients requiring palliative care, those with brain or bone metastasis and those with inherited renal cell carcinoma are discussed.
Brian I. Rini, MD, Associate Professor Department of Solid Tumor Oncology and Urology, Cleveland Clinic Taussig Cancer Center, Associate Professor of Medicine Cleveland Clinic Foundation/ Case Western Reserve, University Lerner College of Medicine Cleveland, OH. Steven C. Campbell, MD, PhD Professor of Surgery, Section of Urological Oncology Glickman Urological Institute Cleveland Clinic Foundation Cleveland, OH.
Introduction - Rini/Campbell
1: Pathology - (Zhou, CCF)
2: Epidemiology and Screening of RCC (Godley)
3: Diagnosis and Management of Inherited RCC(Nathanson/Stephenson)
4: Genetics of Sporadic RCC (Bin Teh)
5: Imaging Techniques (Herts)
6: Management of Small Renal Masses
a: Biopsy (Uzzo)
b: Non-invasive Techniques (Matin)
c: Partial Nephrectomy (Novick)
7: Prognostic Factors in Localized RCC (Pantuc, Belldegrun)
8: Radical Nephrectomy for Localized RCC (Samir Taneja - NYU)
9: Surgical Management of Locally-Advanced RCC (Wood)
10: Adjuvant Therapy in RCC (Eisen-Caimbridge)
11: Prognostic Factors in Metastatic RCC (Choueiri-CCF)
12: Immunobiology of Metastatic RCC (Jim Finke - CCF)
13: Immunotherapy in Metastatic RCC (David McDermott - BI)
14: Angiogenesis Biology in Metastatic RCC (Kim Rathmell - UNC)
15: Anti-VEGF Therapy in Metastatic RCC
a: VEGF Ligand-binding Agents (Rini/Rathmell)
b: Therapeutic Inhibition of VEGF Receptor (Oliver Rixe - France)
16: Akt Pathway Biology in Metastatic RCC (Dan George - Duke)
17: Therapeutic mTOR Inhibition in Metastatic RCC (Gary Hudes - FCCC)
18: Future Therapeutics in Metastatic RCC (Keith Flaherty - Penn)
19: Surgical Management of Metastatic RCC (Evans, Rini and Campbell)
20: Supportive Care in Metastatic RCC
a: Biphosphonates (Michelson - MGH)
b: Management of CNS Metastases (Hutson - Baylor)
c: Palliative Care Considerations (Davis - CCF)
| Erscheint lt. Verlag | 16.8.2009 |
|---|---|
| Verlagsort | Shelton |
| Sprache | englisch |
| Maße | 222 x 287 mm |
| Gewicht | 1 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Nephrologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| ISBN-10 | 1-60795-003-0 / 1607950030 |
| ISBN-13 | 978-1-60795-003-5 / 9781607950035 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
